Cargando…
Emerging evidence of anti-tumor immune control in the central nervous system
Microarray-based studies by our laboratory confirm that the immune control of tumor progression extends to the “immunoprivileged” central nervous system, identifying prognostic immune gene signatures in primary tumor specimens. Our results provide rationale and mechanistic insights for the developme...
Autores principales: | Donson, Andrew M., Foreman, Nicholas K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525633/ https://www.ncbi.nlm.nih.gov/pubmed/23264924 http://dx.doi.org/10.4161/onci.21747 |
Ejemplares similares
-
Immunotherapeutic implications of the immunophenotype of pediatric brain tumors
por: Griesinger, Andrea M, et al.
Publicado: (2014) -
A novel bispecific antibody recruits T cells to eradicate tumors in the “immunologically privileged” central nervous system
por: Choi, Bryan D., et al.
Publicado: (2013) -
Alerting the immune system via stromal cells is central to the prevention of tumor growth
por: Issazadeh-Navikas, Shohreh
Publicado: (2013) -
Host CD73 impairs anti-tumor immunity
por: Salmi, Marko, et al.
Publicado: (2012) -
A novel role for granzymes in anti-tumor immunity
por: Hoves, Sabine, et al.
Publicado: (2012)